<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Udayar V</submitter><funding>Intramural NIH HHS</funding><funding>NIA NIH HHS</funding><funding>NIDA NIH HHS</funding><funding>Medical Research Council</funding><funding>Alzheimers Research UK</funding><funding>Wellcome Trust</funding><pagination>1536-51</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4004174</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5(6)</volume><pubmed_abstract>Alzheimer's disease (AD) is characterized by cerebral deposition of ?-amyloid (A?) peptides, which are generated from amyloid precursor protein (APP) by ?- and ?-secretases. APP and the secretases are membrane associated, but whether membrane trafficking controls A? levels is unclear. Here, we performed an RNAi screen of all human Rab-GTPases, which regulate membrane trafficking, complemented with a Rab-GTPase-activating protein screen, and present a road map of the membrane-trafficking events regulating A? production. We identify Rab11 and Rab3 as key players. Although retromers and retromer-associated proteins control APP recycling, we show that Rab11 controlled ?-secretase endosomal recycling to the plasma membrane and thus affected A? production. Exome sequencing revealed a significant genetic association of Rab11A with late-onset AD, and network analysis identified Rab11A and Rab11B as components of the late-onset AD risk network, suggesting a causal link between Rab11 and AD. Our results reveal trafficking pathways that regulate A? levels and show how systems biology approaches can unravel the molecular complexity underlying AD.</pubmed_abstract><journal>Cell reports</journal><pubmed_title>A paired RNAi and RabGAP overexpression screen identifies Rab11 as a regulator of ?-amyloid production.</pubmed_title><pmcid>PMC4004174</pmcid><funding_grant_id>AG021495</funding_grant_id><funding_grant_id>Z01 AG000950</funding_grant_id><funding_grant_id>R21 DA036086</funding_grant_id><funding_grant_id>ZO1 AG000950-10</funding_grant_id><funding_grant_id>ARUK-TRFUS2012-3</funding_grant_id><funding_grant_id>R01 AG019070</funding_grant_id><funding_grant_id>R01 AG021495</funding_grant_id><funding_grant_id>WT089698</funding_grant_id><funding_grant_id>AG019070</funding_grant_id><funding_grant_id>ZIA AG000950-10</funding_grant_id><funding_grant_id>MC_G1000735</funding_grant_id><funding_grant_id>089698</funding_grant_id><pubmed_authors>Siegel G</pubmed_authors><pubmed_authors>Rajendran L</pubmed_authors><pubmed_authors>Hardy J</pubmed_authors><pubmed_authors>Puthenveedu MA</pubmed_authors><pubmed_authors>Lupton MK</pubmed_authors><pubmed_authors>Ries J</pubmed_authors><pubmed_authors>Guerreiro R</pubmed_authors><pubmed_authors>Sassi C</pubmed_authors><pubmed_authors>Powell J</pubmed_authors><pubmed_authors>Bras J</pubmed_authors><pubmed_authors>Soohoo AL</pubmed_authors><pubmed_authors>Singleton A</pubmed_authors><pubmed_authors>Guerreiro RL</pubmed_authors><pubmed_authors>Udayar V</pubmed_authors><pubmed_authors>Hernandez D</pubmed_authors><pubmed_authors>Morgan K</pubmed_authors><pubmed_authors>Gibbs JR</pubmed_authors><pubmed_authors>Ponnusamy M</pubmed_authors><pubmed_authors>AESG</pubmed_authors><pubmed_authors>Buggia-Prevot V</pubmed_authors><pubmed_authors>Thinakaran G</pubmed_authors><pubmed_authors>Bali J</pubmed_authors><pubmed_authors>Simons M</pubmed_authors><pubmed_authors>Siegenthaler B</pubmed_authors><pubmed_authors>Brown K</pubmed_authors><pubmed_authors>Rambabu N</pubmed_authors></additional><is_claimable>false</is_claimable><name>A paired RNAi and RabGAP overexpression screen identifies Rab11 as a regulator of ?-amyloid production.</name><description>Alzheimer's disease (AD) is characterized by cerebral deposition of ?-amyloid (A?) peptides, which are generated from amyloid precursor protein (APP) by ?- and ?-secretases. APP and the secretases are membrane associated, but whether membrane trafficking controls A? levels is unclear. Here, we performed an RNAi screen of all human Rab-GTPases, which regulate membrane trafficking, complemented with a Rab-GTPase-activating protein screen, and present a road map of the membrane-trafficking events regulating A? production. We identify Rab11 and Rab3 as key players. Although retromers and retromer-associated proteins control APP recycling, we show that Rab11 controlled ?-secretase endosomal recycling to the plasma membrane and thus affected A? production. Exome sequencing revealed a significant genetic association of Rab11A with late-onset AD, and network analysis identified Rab11A and Rab11B as components of the late-onset AD risk network, suggesting a causal link between Rab11 and AD. Our results reveal trafficking pathways that regulate A? levels and show how systems biology approaches can unravel the molecular complexity underlying AD.</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Dec</publication><modification>2020-11-19T10:03:43Z</modification><creation>2019-03-27T01:27:17Z</creation></dates><accession>S-EPMC4004174</accession><cross_references><pubmed>24373285</pubmed><doi>10.1016/j.celrep.2013.12.005</doi></cross_references></HashMap>